Allogeneic stem cell-derived "repair unit" therapy and the barriers to clinical deployment.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 15100353.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The development of cellular therapies has been seriously hampered by the paucity of cells available for grafting from living or cadaver donors. This sourcing problem can be resolved, at least in theory, by generating tissue-specific cells from autologous or allogeneic stem cells. Nonetheless, there are formidable barriers to the use of stem cells in the clinic. This review focuses on identifying and surmounting these barriers.
Medical subject headings
- Kidney
- Kidney Failure, Chronic
- Stem Cell Transplantation